Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calendar
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Dx World Summit
  • About
    • Editorial Profile
    • Editorial Calendar
    • Contact
  • Dx World Summit
 
  • Mapping the Vagus Nerve: Researchers Look to Pave the Way for Bioelectronic Breakthroughs

    Diagnostics World News | Researchers have their sights set on creating a first-of-its-kind anatomical map of the vagus nerve. Stavros Zanos of the Feinstein Institutes for Medical Research is leading a three-year-long research study called Reconstructing Vagal Anatomy. The NIH-supported project plans to share the map with the greater scientific community in hopes of leading to new breakthroughs in the field of bioelectronic medicine.

    Dec 8, 2022
  • Tumor Fraction Shows Promise as Tumor-Agnostic Prognostic Tool

    Diagnostics World News | A research team from The Ohio State University and Foundation Medicine suggests that tumor fraction has the potential to serve as a pragmatic, tumor-agnostic prognostic tool. They published their results in Annals of Oncology last month.

    Dec 6, 2022
  • Saliva-Based Test to Diagnose Concussions, Blood Test Detects Cancer Two Years Before Formal Diagnosis, More

    Diagnostics World News | A deep learning model that uses a single chest X-ray to predict the 10-year risk of death from a heart attack or stroke; a new blood test to improve early detection and diagnosis of clinically significant prostate cancer in patients by minimizing unnecessary invasive tissue biopsies; real-time PCR technology to screen for spinal muscular atrophy and severe combined immunodeficiency using a single dried blood spot sample; and more.

    Nov 30, 2022
  • Follow the Money: Ultrasensitive ctDNA Personalized Cancer Diagnostic Test, Advanced Brain Cancer Diagnostics, More

    Diagnostics World News | Funding for chronic kidney disease and acute kidney injury genetic testing, minimal residual disease testing for solid tumors, and more.

    Nov 29, 2022
  • «
  • 71
  • 72 (current)
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy